Six-month randomized clinical trial comparing intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

被引：3

|

作者：

Fellenbaum, PS

机构：

来源：

AMERICAN JOURNAL OF OPHTHALMOLOGY | 2003年 / 136卷 / 02期

关键词：

D O I：

10.1016/S0002-9394(03)00247-2

中图分类号：

R77 [眼科学];

学科分类号：

100212 ;

摘要：

引用

收藏

页码：392 / 392

页数：1

相关论文

共 50 条

[31] Late-day intraocular pressure–lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
Harvey B DuBiner
Douglas A Hubatsch
BMC Ophthalmology, 14
[32] Fixed-combination intraocular pressure-lowering therapy for glaucoma and ocular hypertension: advantages in clinical practice
Hollo, Gabor
Topouzis, Fotis
Fechtner, Robert D.
EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (12) : 1737 - 1747
[33] Efficacy and Safety of Bimatoprost as Replacement for Latanoprost in Patients With Glaucoma or Ocular Hypertension A Uniocular Switch Study
Casson, Robert J.
Liu, Lance
Graham, Stuart L.
Morgan, William H.
Grigg, John R.
Galanopoulos, Anna
Crawford, Andrew
House, Philip H.
JOURNAL OF GLAUCOMA, 2009, 18 (08) : 582 - 588
[34] Efficacy and safety of brimonidine and dorzolamide for intraocular pressure lowering in glaucoma and ocular hypertension
Katz, L. Jay
Simmons, Steven T.
Craven, E. Randy
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (12) : 2971 - 2983
[35] Three-month comparison of brimonidine and latanoprost as adjunctive therapy in glaucoma and ocular hypertension patients uncontrolled on β-blockers -: Tolerance and peak Intraocular pressure lowering
Simmons, ST
Earl, ML
OPHTHALMOLOGY, 2002, 109 (02) : 307 - 314
[36] A randomized clinical trial comparing three fixed combinations of bimatoprost with timolol in patients with open-angle glaucoma or ocular hypertension
Mrukwa-Kominek, Ewa
Misiuk-Hojlo, Marta
Csutak, Adrienne
Stalmans, Ingeborg
Garhofer, Gerhard
CURRENT MEDICAL RESEARCH AND OPINION, 2023, 39 (05) : 775 - 783
[37] Effects on intraocular pressure in primary open-angle glaucoma after combined therapy with latanoprost and bimatoprost: A randomized clinical trial
Doi, LM
Melo, LAS
Prata, JA
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2004, 45 : U672 - U672
[38] Twelve-Month, Randomized, Controlled Trial of Bimatoprost 0.01%, 0.0125%, and 0.03% in Patients with Glaucoma or Ocular Hypertension
Katz, L. Jay
Cohen, John S.
Batoosingh, Amy L.
Felix, Carlos
Shu, Vincent
Schiffman, Rhett M.
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2010, 149 (04) : 661 - 671
[39] Effects of the combination of bimatoprost and latanoprost on intraocular pressure in primary open angle glaucoma: a randomised clinical trial
Doi, LM
Melo, LAS
Prata, JA
BRITISH JOURNAL OF OPHTHALMOLOGY, 2005, 89 (05) : 547 - 549
[40] A combined analysis of four observational studies evaluating the intraocular pressure-lowering ability and tolerability of bimatoprost 0.01% in patients with primary open-angle glaucoma or ocular hypertension
Stevens, Annemie
Iliev, Milko E.
de Jong, Leo
Grobeiu, Ioana
Hommer, Anton
CLINICAL OPHTHALMOLOGY, 2016, 10 : 635 - 641

← 1 2 3 4 5 →